Antiva Biosciences (Series D)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$50,000,000

Company Info
Founders
Kristine Ball
Company Description
Topical treatment for precancerous lesions for cervical cancer. Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.
Market
Healthcare & Wellness
Coinvestors
Adjuvant Capital,Google Ventures (GV)

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement